CytomX Therapeutics (CTMX) Intangibles (2014 - 2026)
CytomX Therapeutics' Intangibles was $365,000 in Q2 2026, down 28.4% from $510,000 a year earlier and down 9.0% from the prior quarter.
Powered by 
Analysis
CytomX Therapeutics (CTMX) Intangibles (2014 - 2026) Analysis & Trends
At the end of FY2025, Intangibles at CytomX Therapeutics came in at $438,000, down 24.9% from FY2024.
- Intangibles has now declined for nine consecutive years, with a five-year compound annual growth rate of -17.8% (FY2020 to FY2025).
- In earlier years, Intangibles was $583,000 in FY2024 (-20.0%), $729,000 in FY2023 (-16.7%), $875,000 in FY2022 (-14.3%) and $1.02 million in FY2021 (-12.5%).
- The Q2 2026 figure marks the lowest quarterly Intangibles in data going back to Q4 2014.
- Compared with a year earlier, Intangibles has declined for 36 straight quarters, with an average decline of 23.2% over the last eight quarters.
- The year-over-year decline in Intangibles has ranged between 12.1% (Q3 2021) and 28.4% (Q2 2026) over the last five years.
- Per Business Quant data, CTMX's Intangibles in the three quarters before Q2 2026 was $401,000 (Q1 2026), $438,000 (Q4 2025) and $474,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 48.23 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 49.14 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 24.98 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 42.07 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 37.72 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 20.49 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 14.03 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 47.05 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 412.80 Mn |
| 10 | CytomX Therapeutics | 599.22 Mn | -358.44 Mn | - | 365,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 365,000.00 |
| Mar 31, 2026 | 401,000.00 |
| Dec 31, 2025 | 438,000.00 |
| Sep 30, 2025 | 474,000.00 |
| Jun 30, 2025 | 510,000.00 |
| Mar 31, 2025 | 547,000.00 |
| Dec 31, 2024 | 583,000.00 |
| Sep 30, 2024 | 620,000.00 |
| Jun 30, 2024 | 656,000.00 |
| Mar 31, 2024 | 693,000.00 |
| Dec 31, 2023 | 729,000.00 |
| Sep 30, 2023 | 766,000.00 |
| Jun 30, 2023 | 802,000.00 |
| Mar 31, 2023 | 839,000.00 |
| Dec 31, 2022 | 875,000.00 |
| Sep 30, 2022 | 911,000.00 |
| Jun 30, 2022 | 948,000.00 |
| Mar 31, 2022 | 984,000.00 |
| Dec 31, 2021 | 1.02 Mn |
| Sep 30, 2021 | 1.06 Mn |
API Access
CytomX Therapeutics Intangibles API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=intangibles&ticker=CTMX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "intangibles", "ticker": "CTMX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=intangibles&ticker=CTMX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();